fbpx
Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

A potential non-invasive stool test and novel therapy for endometriosis

Written by | 16 Oct 2024

Promising findings by researchers at Baylor College of Medicine and collaborating institutions could lead to the development of a non-invasive stool test and a new therapy for endometriosis, a painful… read more.

Women with endometriosis at greater associated risk of heart attack and stroke

Written by | 11 Sep 2024

According to research presented at ESC Congress 2024,1 women with endometriosis have a 20% greater risk of significant cardiac outcomes compared with women without endometriosis. “For decades, cardiovascular… read more.

Landmark study shows elevated cancer risk for women with endometriosis

Written by | 1 Aug 2024

A landmark study from researchers at Huntsman Cancer Institute at the University of Utah (the U), the Spencer Fox Eccles School of Medicine at the U, and Boston University Chobanian & Avedisian School of Medicine found… read more.

A hydrogel implant to treat endometriosis

Written by | 25 Jul 2024

Hydrogels have a variety of use cases, including contact lenses, delivering doses of medication within the body, moisturisers, water storage in soil, cleaning polluted water and as gelling… read more.

What women want: Female experiences to manage pelvic pain

Written by | 18 Apr 2024

A new study from the University of South Australia is putting people’s experiences of pelvic pain at the front of pain education to develop better pain management strategies and improved outcomes. Persistent… read more.

Exploring the effectiveness of a novel pain management device for endometriosis pain

Written by | 13 Mar 2024

Endometriosis is a chronic condition affecting women, often resulting in painful symptoms such as menstrual cramps and pelvic pain. Pain caused by endometriosis significantly lowers the quality of… read more.

European Commission approves Ryeqo (relugolix 40 mg, estradiol 1.0 mg, and norethisterone acetate 0.5 mg) to treat endometriosis – Gedeon Richter

Written by | 9 Nov 2023

Gedeon Richter Plc. together with Sumitomo Pharma America, Inc. and Sumitomo Pharma Switzerland, GmbH has announce that the European Commission (‘EC’) has granted approval of a Type II… read more.

Genetics links endometriosis and IBS

Written by | 29 Oct 2023

University of Queensland researchers have shown that endometriosis and irritable bowel syndrome (IBS) share genetic risk factors, explaining why patients with one condition may also have the other…. read more.

Health Canada approves Myfembree to manage moderate to severe pain associated with endometriosis – Sumitomo Pharma Canada + Pfizer Canada

Written by | 26 Oct 2023

Sumitomo Pharma Canada, Inc. and Pfizer Canada announced that Health Canada has granted a Notice of Compliance (NOC) for Myfembree (Relugolix, estradiol and norethindrone acetate tablets) for the… read more.

AI could shorten the diagnostic journey of millions suffering from endometriosis

Written by | 14 Aug 2023

The quality of life of millions suffering from endometriosis – a painful disease where sensitive tissue grows outside of the uterus – could be improved by a new… read more.

New research shows potential to reduce pain in women suffering from endometriosis

Written by | 6 Aug 2023

Pelvic pain in women with endometriosis is attributed to neuroinflammation. Researchers investigated biochemical mediators of endometriosis-associated pelvic pain to provide a foundation to identify new drugs to improve… read more.

UK’s young people at risk of leaving school without vital knowledge of reproductive health, study finds

Written by | 16 Jul 2023

Pupils in the UK are not learning about potentially life-changing issues such as endometriosis, infertility, and miscarriage, according to a new study of curricula in science and in… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.